New IQVIA numbers show Foundayo prescriptions falling to 58,014 from 60,151 the week before, while Novo's pill held roughly flat.
Recap by typeshit. Post by Investseekers on X.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
The latest edition of FiercePharma's tracker reports a slight drop for both oral weight loss pills after their early prescription climb.
Medical Xpress covers an implant approach to type 2 diabetes that uses a small catalyst to bring glucose down. Not a peptide or GLP-1 story.
Loading…